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for the established clinical risk factors, dilation of the LAD, current smoking
and angina class.
Multiple linear regression analysis showed that luminal renarrowing could
be predicted reliably (R2 = 0.65; P < 0.0001) in this patients group on the
basis of the vessel dilated and only two biological risk factors that reflect
the activation status of blood phagocytes, i.e., the expression of C066 by
granulocytes and the production of IL-l,B by stimulated monocytes.
Conclusions. The results of the present study indicate that activated blood
granulocytes prevent luminal renarrowing after PTCA. while activated blood
monocytes promote restenosis. To validate this new finding further study in
an independent patients group is required.
Cardiac Allograft Vasculopathy
output (CO) were serially measured. In Group II, III and IV, all hearts were pre-
served with CCMP technique in hypothermia for 24 hours. Initial perfusion
pressure of CCMP was set to 5 mmHg with constant flow and the pressure
was monitored during the preservation. After all experimental protocol, tis-
sue water content (tWC) was measured. And ultrastructural findings of my-
ocardium and endothelial cells were evaluated. Recovery rate (post/pre;%)
of cardiac functions. CCM P pressure after 24 hours and tWC were as fol-
lows. In Group IV, ultrastructural findings showed minimal myocardial and
endothelial injury among preservation groups.
% sAP %AF %CF %CO CCMPpress. %tWC
Group I 99.7 ± 0.5 99.7 ± 0.5 99.7± 0.5 99.7± 0.5 (-) 82.2:1: 0.3
Group II 78.0 ± 8.2 52.8 ± 26.5 62.6:1:17.7 56.0±212 11.3:1:2.2 66.3±21.2·
Group III 87.1 ± 6.8 83.5± 10.7t 82.3± 12.0t 82.8± 8.9 t 8.2±1.3t 83.2:1: 2.9
Group IV 91.5 ± 4.2 89.2 ± 9.21 96.5±11.71 91.5± 5.41 5.2:1:0.21 84.7:1: 17
% Change in Vascular Wall Cell Proliferation
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This inhibitory effect of estradiol treatment on the mitogenic effect of IGF-I
and IL-6 on the vascular wall of the allograft supports previous studies show-
ing that accelerated coronary transplant arteriosclerosis in this model is in-
hibited by estrogen. These data speak to the use of hormone replacement
therapy in post menopausal women receiving a cardiac transplant.
Intrathymic Injection of Donor Splenocytes
Prolongs Rat Cardiac Allograft Survival but Does
not Inhibit Graft Arteriosclerosis
Yang T. Shin, David H. Adams. Lauri R. Wyner, Enver Akalin, Mohamed H. Sayegh.
Morris J. Karnovsky. Harvard Medical School, Boston, MA
GROUPS Inflammation % Vessels % Luminal Intima:Media
Diseased Occlusion Ratio
Control (A) severe 89 ± 1 64± 5 0.97 ± 0.33
Splenocyte only (e) moderate-severe 79 ± 8 57 ± 7 068:1: 0.16
ALS only (B) minimal 25 ± 7*' 8± 3·· 0.09 ± 0.04'
Splenocyte + ALS (D) minimal 27 ±4" 8 ± 3" 0.07:1: 0.03'
Chronic rejection, manifested by the development of graft arteriosclerosis.
remains the leading cause of late death in cardiac transplant recipients. Im-
munologic mechanisms have been implicated in both experimental and clini-
cal studies. yet the pathogenesis of chronic allograft rejection remains poorly
understood. Recent studies have shown that intrathymic (i.t.) injection of
donor cells or processed allo-MHC antigens with or without transient im-
munosuppression induces specific systemic T cell tolerance and prevents
acute allograft rejection in several experimental transplantation models. In
this study we examined the effects of i.t. injection of donor cells with or with-
out systemic anti-lymphocyte serum (ALS) on the development of chronic
rejection in the Lewis-to-F344 rat cardiac allograft model. Recipients were
divided into 4 groups: control group A was pre-treated with saline i.t., group
B was pre-treated with a one-time dose of ALS (1 mil via intraperitoneal in-
jection (i.p.). group C received donor (Lewis) splenocytes i.t. (2 x 106), and
group D received both the splenocytes i.t. and a one-time dose of ALS i.p.
two weeks prior to transplantation. Allografts were followed by daily palpa-
tion and graded from Q-4 (grade 0 = rejection, grade 4 = normal heartbeat).
Graft survival on post-op day 90 for all three experimental groups was 100%
vs. 33% for the control (n = 6/group). Moreover, mean heartbeat grade for
the three experimental groups (B = 2.83 ± 0.17, C = 2.0 ± 0.41. 0 = 2.67
± 0.21) was significantly higher (p < 0.01) than that of the control group (A
= 0.4 ± 0.24). Histologic and immunocytochemical analysis of 90-day old
grafts revealed the following results:
'p < 0.05 Group I vs II, t P< 0.05 Group II vs III. I p < 0.05 Group III vs IV
Conclusions: 1I CCMP with oxygenated UWs improved post-ischemic car-
diac functions and suppressed tissue edema in prolonged heart preser-
vation. 2) Addition of ETA antagonist suppressed damaged endothelium-
dependent vasoconstriction and also showed excellent functional recovery
and minimal myocardial injury.
'p < 0.02. "p < 0.003 vs. Control
1936-851
Chronic Estradiol Treatment of Rabbits with
Cardiac Allografts Attenuates Graft Vascular
Proliferation Induced by Insulin-like Growth
Factor-I (IGF-I) and Interleukin-6 (IL-6)
IGF-I (20 Itg/ml) INF-y (50 U/ml) IL.£ (50 U/ml)
Native
- Estradiol 175 ± 32 189 ± 43 162± 28
+ Estradiol 167 ± 42 143 ± 79 159 ± 36
Allograft
- Estradiol 328 ± 66 197 ± 56 366 ± 101
+ Estradiol 64± 12 116±41 72± 14
Mean ± SEM
Hong Lou, Teruaki Kodama, Nevin Katz, Marie Foegh. Georgetown University
Medical Center, Washington, DC
Male New Zealand White rabbits fed a 0.5% cholesterol diet (n = 13) re-
ceived a heterotopic cardiac allograft and cyclosporine (10 mg/kg/day) until
sacrifice 6 to 7 weeks later, at which time both the native and transplanted
hearts and aorta were harvested. Six of the rabbits were treated with estra-
diol 100 Itglkg/day i.m.. beginning 7 days prior to transplantation and con-
tinuing until sacrifice; the remaining seven rabbits served as controls and
received placebo. The native aorta as well as the aorta from the grafted
hearts were isolated and used for in vitro studies involving cytokine and
growth factor stimulated cell proliferation. Tritiated thymidine incorporation
is expressed as CPM/mg protein and the changes in cell proliferation are
expressed as % changes from the control (the unstimulated vessel). IGF-I
and IL-6 but not interferon-y (INF-y) significantly increased cell proliferation,
measured as 3H-thymidine incorporation. in explants from both native and
allograft vessels and significantly more so in the graft (p < 0.05). The mito-
genic effect of both IGF-I and IL-6 in the graft aorta, but not in that associated
with the native heart, was abrogated by chronic treatment with estradiol (p
< 0.02).
1936-831
Kenji Okada, Chojiro Yamashita, Morihito Okada. Masayoshi Okada. Kobe
University. Department ofSurgery. Division /I
Prolonged heart preservation by simple cold storage in University of Wis-
consin solution (UWs) and its deteriorative effect on endothelial function
have been problematic. We have studied whether continuous coronary
microperfusion (CCMP) technique with oxygenated UWs improves post-
ischemic functional recovery and addition of endothelin (ET) A receptor
antagonist (FR139317) reduces damaged endothelium-dependent vasocon-
striction. Twenty three isolated hearts of Japanese white rabbits were di-
vided into four groups according to preservation methods or modification of
UWs. Group I (control non-preserved). Group II (with original UWs), Group
III (with oxygenated UWs) and Group IV (with oxygenated UWs contained
10 mgll of FR139317). Cardiac functions of isolated hearts were evaluated
by Langendorf! apparatus. As pre and post-ischemic functional parameters,
systolic aortic pressure (sAP), aortic flow (AF), coronary flow (CF) and cardiac
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1936-841 Efficacy of Endothelin A Receptor Antagonist(FR139317) for Long-term Heart Preservation
Conclusions: (1) The induction of systemic unresponsiveness with donor
splenocyte i.t. plus ALS i.p. or ALS i.p. alone markedly reduced inflamma-
tion and inhibited graft arteriosclerosis indicating that the immune response
and graft inflammation playa critical role in the pathogenesis of chronic al-
lograft rejection. (2) The donor cells 1.1. alone significantly prolonged graft
survival and prevented rejection as measured by functional criteria but did
not significantly inhibit graft inflammation or graft arteriosclerosis. These re-
sults suggest that partial suppression of the immune response without sig-
nificant inhibition of graft inflammation prolongs rat cardiac allograft survival
but does not prevent graft arteriosclerosis.
Plasma Fibrinogen Level Predicts Severity of
Intimal Thickening After Cardiac Transplantation
Clyde R. Meckel. Todd J. Anderson, Gilbert H. Mudge, Peter Ganz. Daniell. Simon.
Brigham and Women's Hospital, Boston. MA
Diffuse atherosclerosis is the primary reason for late graft failure after car-
diac transplantation. Because there is increasing evidence that imbalances
in the hemostatic and fibrinolytic pathways are associated with allogeneic re-
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2.8 ± 4'
Focal < 500
In ~ 14}
23 ± 0.6'
Focal> 500
(n ~ 7)
37 ± 0.7
Diffuse < 500
(n ~ 18)
3.3 ± 0.4
Diffuse> 500
In ~ 19)
31 ± 0.5
None
In ~ 12)
Extent of Coronary Myointimal Proliferation and
its Relationship to Resistance Vessel Function in
the Cardiac Allograft
Thomas Wolford, Thomas J. Donohue, John H. Drury, Richard G. Bach, Eugene
A. Caracciolo, Andrew S. Potash, Stephen H. Jennison, Morton J. Kern, Pamela
S. Pelgh. St Louis University Medical Center, St Louis, MO
p < 0.01 vs diffuse
CFR
1936-891
Impact of Ischemia Time on Vascular Rejection
and Expression of Peptide Growth Factors in
Transplant Arteriosclerosis
J. Waltenberger 1,2, L. AkyOrek 2. A. Wanders 2, B. Fellstrbm 2, K. Funa 2. 1Dept.
of Medicine, VIm University Medical Center; D,' 2 Ludwig Institute for Cancer Research
and Uppsala University, Uppsala, 5
pts were subdivided into older ('2:40) and younger «40) groups. Freedom
from TxCAD was 92%, 52%, and 43% at 1, 3, and 5 years post-op in the
older group In = 31, mean age 49) vs. 97%, 82%, and 53% in the younger
group (n = 184, mean age 24) p = 0.03 (Mantel-Haenszel).
Baseline ICUS imaging revealed baseline class 3 or 4 lesions in 7 of 9
older donor hearts, and in only 7 of 32 younger hearts (p = 0.006). Three
of these 14 ICUS class 3/4 pts later developed TxCAD vs. only 3 of 27 class
1/2 pts at baseline (p = NS). Older donor age, no calcium blocker use and
pre-existing CAD were significant predictors for development of TxCAD (p =
0.0006,0.0003, and 0.003 respectively, Cox regression analysis).
Conclusion: (1) Older donors or pre-existing CAD have a greater tendency
to develop TxCAD, (2) ICUS reveals moderate to severe intimal thickening not
angiographically detectable and there is a trend toward such disease leading
to later TxCAD.
Transplant coronary arteriopathy is the major obstacle to long-term survival
of cardiac allografts and is characterized by myointimal proliferation involv-
ing both epicardial conduit vessels and intramyocardial resistance vessels.
To evaluate the relationship between conduit disease and resistance vessel
integrity, 70 coronary arteries in 58 transplant patients were studied with a
3.5 Fr 30 MHz intravascular ultrasound (IVUS) probe and an 0.018" doppler
guidewire. Epicardial conduit disease was characterized by the presence or
absence of IVUS discernible intimal thickening, (>500 microns or <500 mi-
cronsl in either a diffuse (trilaminar appearance along whole course of stud-
ied segment) or a focal (with areas of vessel free of intimal thickening) dis-
tribution. Resistance vessel function was assessed by measuring coronary
flow reserve (CFR ~ maximal hypermiclresting blood flow velocity) using in-
tracoronary adenosine (18 mg). Results (means ± SD):
There were no differences in the CFR between arteries with (n = 58) and
without (n = 12) intimal thickening (3.2 ± 0.6 vs 3.1 ± 0.5; p ~ NSI or based
on the maximal thickness of the intima «500 microns, 3.2 ± 8 vs >500 mi-
crons 3.0 ± 0.7, P = NS). Extensive myointimal thickening can occur without
diminishment of the CFR. Focal intimal disease is associated with a signif-
icantly more profound effect on microvascular function then classically de-
scribed diffuse disease. This suggests that typical epicardial transplant arte-
riopathy can occur without involvement of small vessels.
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Serial Dobutamine Stress Echocardiography for
Detection of Cardiac Allograft Vasculopathy
Christoph H. Spes, Harald Mudra, Susanne D. Schnaack, Johannes Rieber,
Florian Reichle, Thomas M. KrOger, Volker Klauss, Peter Uberfuhr, Bruno Meiser,
Christiane E. Angermann, Karl Theisen. University of Munich. Germany
Dobutamine stress echocardiography (DSE) is a noninvasive and safe test
to detect myocardial ischemia. To analyse, if DSE is feasible for assessment
and follow up of coronary allograft vasculopathy (CAV), 13 patients (R 50
+/~ 8 years, 60 +1= 32 months after heart transplantation) were studied
at 2 consecutive routine annual investigations by coronary angiography (AN-
GlO), intravascular ultrasound (IVUS quantitative analysis of degree and ex-
tension of intimal hyperplasia; modified Stanford grading, grades 1--B) and
dobutamine stress echocardiography(DSE, 5-40 mcglkg/min, 5 min stages).
Regional wall motion abnormalities (WMA) were assessed qualitatively (2-D-
echo, 16 segment model1and quantitatively 1M-Mode, systolic thickening of
interventricular septum (IVS) and LV posterior wall (LPW)I.
Results: P were allocated to 2 groups: group 1, normal DSE at entry (n
= 9); group 2, WMA during DSE at entry (n = 4). At the initial study, no
P had WMA at rest. In group 1, IVUS revealed only mild intimal hyperplasia
Imean, < grade 3.5) in group-l P; ANGlO was completely normal in 8/9 P and
showed mild dilating angiopathy in 119 P. 4 group-2 Pdeveloped WMA during
DSE (total, 12/64 segments); ANGlO was normal in all R IVUS grades were
1.2/1.714.0/5.5. Mean systolic thickening of IVS (rest, 26 vs. 32%; max.DSE,
37 vs. 63%, group 2 vs. 1) and LPW (rest, 35 vs 57% max.DSE, 65 vs. 95%)
were smaller in group 2 than in group 1. At follow up, 3/9 group-l P had DSE-
induced WMA (9/144 segments); all had IVUS progression to grade >3.5,
but no ANGlO changes. In group 2, 1 P with stress induced WMA in only
one segment at entry was judged normal at follow up IIVUS: 1.2 and 1.6,
respectively; false positive DSE at entry). 3 group-2 P deteriorated 1 had
diffuse WMA at rest, all 3 had increasing WMA at DSE (total. 26/48 segments.
Mean IVUS grades rose to 4.015.5/6.0; ANGlO remained normal in 2 P and
showed diffuse rarefication of small vessels in 1 P.
Conclusion: All P with marked-to-severe intimal hyperplasia assessed by
IVUS andlor marked ANGlO findings were identified by DSE. Serial DSE is a
feasible and safe method for noninvasive screening and follow-up for CAy in
heart transplant recipients. In Pwith normal DSE, the need for routine ANGlO
at regular intervals may be reduced.
jection, we hypothesized that atherothrombotic risk factors may contribute
to accelerated atherosclerosis. We therefore prospectively evaluated the
burden of coronary atherosclerosis by intravascular ultrasound (IVUS) in 20
patients and measured plasma fibrinogen (FGNl. lipoprotein (a) (Lp(a)) and
net fibrinolytic activity of plasma using a standard fibrin plate assay. Inti-
mal thickening was quantified using IVUS by measuring the intimal index
(Ii = intimal areal[intimal area + luminal area]) in 2-5 segments of the LAD
using planimetry. The maximal Ii per patient was calculated and indexed
to the time post-transplant (MxlilYr). FGN predicted severity of MxlilYr (r2
= 0.41, p = 0.008). In patients with decreased plasma fibrinolytic activity
(lytic zone < 100 mm21. MxlilYr was increased ten-fold 10.21 ± 0.17 vs.
0.02 ± 0.02, p = 0.002). Because Lp(a) colocalizes with fibrinogen in the
vessel wall and inhibits fibrinolysis, we correlated plasma Lp(a) levels with
the degree of intimal thickening. Lp(a) did not predict MxlilYr (p = NS). In
conclusion, these data suggest that plasma FGN and net fibrinolytic activity
predict the degree of intimal thickening and that fibrin deposition may play
an integral role in diffuse coronary atherosclerosis after cardiac transplan-
tation.
1936-881 Relationship of Donor Age and Pre-existing
Coronary Disease by Angiography and
Intracoronary Ultrasound to Later Development of
Cardiac Allograft Coronary Artery Disease
Shou-Zhou Gao, Sharon A. Hunt, Edwin L. Alderman, Irene R. Hill, Alan C. Yeung,
John S. Schroeder. Stanford University Medical Center, Stanford, California
The increasing demand for cardiac donors has led to a tendency to liberalize
age and other criteria for donor acceptability. Since cardiac allograft coro-
nary artery disease (TxCADI is the major complication limiting longterm post-
transplant survival, we analyzed a series of 242 consecutive cardiac trans-
plant patients (Tx pts) who had baseline early post-op coronary angios and a
subset of 41 pts with baseline intracoronary ultrasound IICUSI to determine
whether either older donor age or pre-existing CAD at the time of transplant
influenced the later occurrence of TxCAD.
Fourteen pts had angiographic evidence of some pre-existing CAD Idonor
CAD group); the other 228 did not (no donor CAD group). New disease was
defined as either development of new obstructive lesions or progression of
old lesions on serial annual angios. Freedom from new disease was 86%,
71 %, and 30% at 1, 2, and 3 years post-op in the donor CAD group and
97%,89%, and 77% in the no donor CAD group (p ~ 0.0031. No donor CAD
Accelerated arteriosclerosis in transplanted organs represents the major
cause of graft failure and is limiting the clinical outcome of heart transplan-
tation.
Using a rat aorta transplant model the impact of cold ischemia time up to
24 hours (extracorporal storage time) and reperfusion injury upon develop-
ment of transplant arteriosclerosis was analysed during the first 2 months
after transplantation both in allogeneic as well as in syngeneic transplants.
The expression of the various isoforms of transforming growth factor-p (TGF-
P), latent TGF-p binding protein (LTBPI as well as platelet-derived growth
factor (pDGF) and its receptors were studied using immunohistochemistry,
followed by a semi-quantitative evaluation and multivariant analysis (n = 18
for each antiserum).
In the syngeneically transplanted aortas the expression of TGF-pl (p <
0031, PDGF-BB (p < 0.05) and of the PDGF a-receptor(p < 0.03) in the neoin-
tima increased significantly with the extent of cold ischemia time. Further-
more, there was a significant induction of LTBP (p < 0.05) correlating with
the observation time after transplantation. In the allogeneic aortic grafts, ex-
pression of all examined proteins was increased soon after transplantation.
In summary, TGF-p and PDGF are induced by allogeneic as well as is-
chemic stimuli in transplanted vessels. Moreover, in the syngeneic trans-
plantation model, cold ischemia time prior to implantation has an impact on
the expression of growth factors and the extent of vascular remodeling.
